Reports

Sale

Philippines Clinical Diagnostics Market

Philippines Clinical Diagnostics Market Size, Share, Trends: By Test: Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Other Tests; By Product: Instruments, Reagents, Other Products; By End User: Hospital Laboratory, Diagnostic Laboratory, Others; Supplier Landscape; 2024-2032

Philippines Clinical Diagnostics Market Outlook

The Philippines clinical diagnostics market size is expected to grow at a CAGR of 4.8% during the forecast period of 2024-2032, driven by rising healthcare and research associated investments, along with the rising incidence of infectious diseases across the region.

 

Philippines Clinical Diagnostics Market Overview

Clinical diagnostics are applied across multiple healthcare domains including infectious disease testing, complete blood count tests, along with liver and renal panels. The rising prevalence of chronic diseases in Philippines has elevated the demand for clinical diagnostics drastically. Being one of the most dynamic economies in the East Asia and Pacific region, Philippines has been witnessing rapid urbanization and an influx of investments to improve the medical sector, bolstering the market growth.

 

Philippines clinical diagnostics market demand is driven by the increasing improvements and adoption of modern technologies to offer better services to the patients. Philippines laboratories are increasingly adopting automated and digital solutions to streamline workflows and enhance accuracy of results. In addition, rising awareness on early disease detection and implementation of numerous screening programs by public as well as private institutions is expected to drive the market growth in the forecast period.

 

Investments in Infrastructure Improvement to Drive the Philippines Clinical Diagnostics Market Growth

In March 2023, the Philippines administration approved 123 new infrastructure projects  worth USD 163 billion. The major investment was made to enhance the research and medical infrastructure in the country, which specific emphasis on building digital connectivity and facilitating remote consultations and services across the country. It is bound to initiate multiple public-private partnerships and boost the overall economic landscape of the region.

 

The Philippines clinical diagnostic market share is expected to increase by increasing integration of cutting-edge technologies. In September 2023, the Consul-General of Japan and Surigao city mayor signed an agreement to grant PHP 3.5 million (USD 62k) to establish mobile x-ray system  in one of the city hospitals. The investment is a testament to rising government initiatives poised at enhancing the infrastructure and making quality services available at an affordable price.

 

Rising Prevalence for Artificial Intelligence

In August 2023, Japan International Cooperation Agency (JICA) and the Philippines Department of Health (DOH) collaborated to bring artificial intelligence (AI) Computer Aided Detection  (CAD) to allow early tuberculosis diagnosis, and eventually help in disease prevention. The latest technology, when applied on 400 suspected tuberculosis patients, led to successful diagnosis in 382 patients, implying its efficacy to analyze infectious diseases. The technology is expected to be used in the detection of other diseases as well, solidifying artificial intelligence integration, which is one of the major Philippines clinical diagnostic market trends.

 

Using Advanced Solutions for Better Patient Outcomes

Over the years, the incidence of cardiovascular diseases and cancer has significantly seen an upswing. Lung, breast, colon, rectum, and prostate cancers are some of the most commonly occurring cancers, affecting around 189 in 100,000 Filipinos. As a result, the demand for improved clinical diagnostics has risen. Focused on providing improved solutions to the patients, the healthcare providers and professionals have been continuously working to upscale their services. For instance, the Manila Doctors Hospital (MDH)  has adopted several quality services to enhance the quality of services. With a new cancer institute and cardiovascular center, equipped with cardiac catheterization laboratory (cath lab), coronary care unit, cardiac rehab, and heart care services, the hospital has been accredited for medical tourism as well.

 

Philippines Clinical Diagnostics Market Segmentation

Market Breakup by Test

  • Lipid Panel
  • Liver Panel
  • Renal Panel
  • Complete Blood Count
  • Electrolyte Testing
  • Infectious Disease Testing
  • Other Tests

 

Market Breakup by Product

  • Instruments
  • Reagents
  • Other Products

 

Market Breakup by End User

  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point of Care Testing
  • Other End Users

 

Philippines Clinical Diagnostics Market Regional Analysis

The market growth can be attributed to an influx of investments from government, non-profit organizations as well as international healthcare companies. With easy availability of resources and academic talent, major MedTech companies are setting up new research facilities in the region, which is poised to boost the Philippines clinical diagnostics market growth in the forecast period. In addition, the growing incidence of geriatric population and a heightened focus on preventing infectious diseases is a notable market driver. In addition, other regions such as Baguio City and Central Luzon are also witnessing expedited market growth, owing to increasing infrastructure improvements.

 

Philippines Clinical Diagnostics Market: Competitor Landscape

In February 2023, Siemens Healthineers and Unilabs  announced EUR 200 million worth collaboration, wherein Unilabs acquired around 400 laboratory analysers to improve their infrastructure and facilitate improved diagnostic services to the consumers. The market has been witnessing a significant boost in merger related activities, with several companies pushing their boundaries to expand their product portfolios. Heightened focus on sustainability and making high-end technology accessible and affordable is a major market trend being adopted by key companies.

 

The key features of the Philippines clinical diagnostics market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Abbott
  • ARUP Laboratories
  • OPKO Health, Inc.
  • Bioscientia Healthcare GmbH
  • Charles River Laboratories
  • NeoGenomics Laboratories
  • Genoptix, Inc.
  • Healthscope
  • The Laboratory Glassware Co.
  • Laboratory Corporation of America Holdings
  • Fresenius Medical Care AG and Co. KGaA
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Siemens Healthcare Private Limited
  • Tulip Diagnostics (P) Ltd.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Test
  • Product
  • End User
Breakup by Test
  • Lipid Panel
  • Liver Panel
  • Renal Panel
  • Complete Blood Count
  • Electrolyte Testing
  • Infectious Disease Testing
  • Other Tests
Breakup by Product
  • Instruments
  • Reagents
  • Other Products
Breakup by End User
  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point of Care Testing
  • Other End Users
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott
  • ARUP Laboratories
  • OPKO Health, Inc.
  • Bioscientia Healthcare GmbH
  • Charles River Laboratories
  • NeoGenomics Laboratories
  • Genoptix, Inc.
  • Healthscope
  • The Laboratory Glassware Co.
  • Laboratory Corporation of America Holdings
  • Fresenius Medical Care AG and Co. KGaA
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Siemens Healthcare Private Limited
  • Tulip Diagnostics (P) Ltd.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Philippines Clinical Diagnostics Market Overview 

    3.1    Philippines Clinical Diagnostics Market Historical Value (2017-2023) 
    3.2    Philippines Clinical Diagnostics Market Forecast Value (2024-2032)
4    Philippines Clinical Diagnostics Market Dynamics
    4.1    Market Drivers and Constraints
    4.2    SWOT Analysis
        4.2.1    Strengths
        4.2.2    Weaknesses
        4.2.3    Opportunities
        4.2.4    Threats
    4.3    Porter’s Five Forces Model
        4.3.1    Bargaining Power of Suppliers
        4.3.2    Bargaining Power of Buyers
        4.3.3    Threat of New Entrants
        4.3.4    Threat of Substitutes
        4.3.5    Degree of Rivalry 
    4.4    Key Demand Indicators
    4.5    Key Price Indicators
    4.6    Industry Events, Initiatives, and Trends 
    4.7    Value Chain Analysis
5    Philippines Clinical Diagnostics Market Segmentation 
    5.1    Philippines Clinical Diagnostics Market by Test
        5.1.1    Market Overview                                         
        5.1.2    Lipid Panel
        5.1.3    Liver Panel
        5.1.4    Renal Panel
        5.1.5    Complete Blood Count
        5.1.6    Electrolyte Testing
        5.1.7    Infectious Disease Testing
        5.1.8    Other Tests
    5.2    Philippines Clinical Diagnostics Market by Product
        5.2.1    Market Overview
        5.2.2    Instruments
        5.2.3    Reagents
        5.2.4    Other Products
    5.3    Philippines Clinical Diagnostics Market by End User
        5.3.1    Market Overview
        5.3.2    Hospital Laboratory
        5.3.3    Diagnostic Laboratory
        5.3.4    Point of Care Testing
        5.3.5    Other End Users
6    Patent Analysis
    6.1    Analysis by Type of Patent
    6.2    Analysis by Publication Year
    6.3    Analysis by Issuing Authority
    6.4    Analysis by Patent Age
    6.5    Analysis by CPC Analysis
    6.6    Analysis by Patent Valuation 
    6.7    Analysis by Key Players
7    Grants Analysis
    7.1    Analysis by Year
    7.2    Analysis by Amount Awarded
    7.3    Analysis by Issuing Authority
    7.4    Analysis by Grant Application
    7.5    Analysis by Funding Institute
    7.6    Analysis by NIH Departments
    7.7    Analysis by Recipient Organization 
8    Funding Analysis
    8.1    Analysis by Funding Instances
    8.2    Analysis by Type of Funding
    8.3    Analysis by Funding Amount
    8.4    Analysis by Leading Players
    8.5    Analysis by Leading Investors
    8.6    Analysis by Geography
9    Partnership and Collaborations Analysis
    9.1    Analysis by Partnership Instances
    9.2    Analysis by Type of Partnership
    9.3    Analysis by Leading Players
    9.4    Analysis by Geography
10    Regulatory Framework
    10.1    Regulatory Overview
11    Supplier Landscape
    11.1    Abbott
        11.1.1    Financial Analysis
        11.1.2    Product Portfolio
        11.1.3    Demographic Reach and Achievements
        11.1.4    Mergers and Acquisitions
        11.1.5    Certifications
    11.2    ARUP Laboratories
        11.2.1    Financial Analysis
        11.2.2    Product Portfolio
        11.2.3    Demographic Reach and Achievements
        11.2.4    Mergers and Acquisitions
        11.2.5    Certifications
    11.3    OPKO Health, Inc.
        11.3.1    Financial Analysis
        11.3.2    Product Portfolio
        11.3.3    Demographic Reach and Achievements
        11.3.4    Mergers and Acquisitions
        11.3.5    Certifications
    11.4    Bioscientia Healthcare GmbH
        11.4.1    Financial Analysis
        11.4.2    Financial Portfolio
        11.4.3    Demographic Reach and Achievements
        11.4.4    Mergers and Acquisitions
        11.4.5    Certifications
    11.5    Charles River Laboratories
        11.5.1    Financial Analysis
        11.5.2    Product Portfolio
        11.5.3    Demographic Reach and Achievements
        11.5.4    Mergers and Acquisitions
        11.5.5    Certifications
    11.6    NeoGenomics Laboratories
        11.6.1    Financial Analysis
        11.6.2    Product Portfolio
        11.6.3    Demographic Reach and Achievements
        11.6.4    Mergers and Acquisitions
        11.6.5    Certifications
    11.7    Genoptix, Inc.
        11.7.1    Financial Analysis
        11.7.2    Product Portfolio
        11.7.3    Demographic Reach and Achievements
        11.7.4    Mergers and Acquisitions
        11.7.5    Certifications
    11.8    Healthscope
        11.8.1    Financial Analysis
        11.8.2    Product Portfolio
        11.8.3    Demographic Reach and Achievements
        11.8.4    Mergers and Acquisitions
        11.8.5    Certifications
    11.9    The Laboratory Glassware Co.
        11.9.1    Financial Analysis
        11.9.2    Product Portfolio
        11.9.3    Demographic Reach and Achievements
        11.9.4    Mergers and Acquisitions
        11.9.5    Certifications
    11.10    Laboratory Corporation of America Holdings
        11.10.1    Financial Analysis
        11.10.2    Product Portfolio
        11.10.3    Demographic Reach and Achievements
        11.10.4    Mergers and Acquisitions
        11.10.5    Certifications
    11.11    Fresenius Medical Care AG and Co. KGaA
        11.11.1    Financial Analysis
        11.11.2    Product Portfolio
        11.11.3    Demographic Reach and Achievements
        11.11.4    Mergers and Acquisitions
        11.11.5    Certifications
    11.12    QIAGEN
        11.12.1    Financial Analysis
        11.12.2    Product Portfolio
        11.12.3    Demographic Reach and Achievements
        11.12.4    Mergers and Acquisitions
        11.12.5    Certifications
    11.13    Quest Diagnostics Incorporated
        11.13.1    Financial Analysis
        11.13.2    Product Portfolio
        11.13.3    Demographic Reach and Achievements
        11.13.4    Mergers and Acquisitions
        11.13.5    Certifications
    11.14    Siemens Healthcare Private Limited
        11.14.1    Financial Analysis
        11.14.2    Product Portfolio
        11.14.3    Demographic Reach and Achievements
        11.14.4    Mergers and Acquisitions
        11.14.5    Certifications
    11.15    Tulip Diagnostics (P) Ltd.
        11.15.1    Financial Analysis
        11.15.2    Product Portfolio
        11.15.3    Demographic Reach and Achievements
        11.15.4    Mergers and Acquisitions
        11.15.5    Certifications
12    Philippines Clinical Diagnostics Market - Distribution Model (Additional Insight)
    12.1    Overview 
    12.2    Potential Distributors 
    12.3    Key Parameters for Distribution Partner Assessment 
13    Key Opinion Leaders (KOL) Insights (Additional Insight)
14    Company Competitiveness Analysis (Additional Insight)

    14.1    Very Small Companies
    14.2    Small Companies
    14.3    Mid-Sized Companies
    14.4    Large Companies
    14.5    Very Large Companies
15    Payment Methods (Additional Insight)
    15.1    Government Funded
    15.2    Private Insurance
    15.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.


* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032, driven by increasing healthcare and research associated investments along with growing prevalence of infectious diseases across the region.

The market demand is driven by the rising emphasis on preventing infectious and fatal chronic diseases via early detection. The increasing integration of modern technologies, such as artificial intelligence and mobile systems, in clinical diagnostics is also fuelling the market demand.

The rising investments focused on improving the healthcare infrastructure is a major market trend. In September 2023, the Consul-General of Japan and Surigao city mayor signed an agreement to grant PHP 3.5 million (USD 62k) to establish mobile x-ray system in one of the city hospitals. Moreover, the government also sanctioned 123 new infrastructure projects worth USD 163 billion.

Based on test, the market is divided into lipid panel, liver panel, renal panel, complete blood count, electrolyte testing, and infectious disease testing, among other tests.

Instruments and reagents, among others are the common technologies available in the market.

Major end users include hospital laboratory, diagnostic laboratory, point of care testing, and others.

Key players involved in the market are Abbott, ARUP Laboratories, OPKO Health, Inc., Bioscientia Healthcare GmbH, Charles River Laboratories, NeoGenomics Laboratories, Genoptix, Inc., Healthscope, The Laboratory Glassware Co., Laboratory Corporation of America Holdings, Fresenius Medical Care AG, and Co. KGaA, QIAGEN, Quest Diagnostics Incorporated, Siemens Healthcare Private Limited, and Tulip Diagnostics (P) Ltd.

Purchase Full Report

Mini Report

$ 1999     $1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3999     $3699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6299     $5699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 8499     $7699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER